Hospital
Appalachian Wellness, L.L.C.
Appalachian Wellness, L.L.C. was paid $12.14M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is T2023, Targeted case management; per month — 33% of everything it billed.
33Billing provider infoAPPALACHIAN WELLNESS, L.L.C.
CAMPTON, KY 41301
CAMPTON, KY 41301
33aNPI1932566544assigned 01/27/2016
33bProvider typePsychiatric Hospital Unit
28Total paid$12.14M
24GClaims212,189
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,874 | $1.35M | |
| 2019 | 29,016 | $1.51M | |
| 2020 | 35,102 | $1.75M | |
| 2021 | 33,199 | $2.06M | |
| 2022 | 32,475 | $1.97M | |
| 2023 | 30,711 | $1.87M | |
| 2024incomplete | 25,812 | $1.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T2023 | Targeted case management; per month | 33% | 12,210 | 10,701 | $4.04M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 25% | 55,431 | 23,052 | $2.98M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 26,659 | 16,604 | $1.28M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 8.1% | 6,141 | 4,273 | $985K |
| H0038 | Self-help/peer services, per 15 minutes | 6.2% | 43,803 | 17,962 | $757K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 6,259 | 5,373 | $374K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.6% | 18,619 | 11,086 | $311K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 10,134 | 5,832 | $265K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1.5% | 822 | 607 | $181K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 1.4% | 1,293 | 236 | $167K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 10,664 | 7,478 | $162K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.1% | 3,216 | 2,397 | $135K |
34 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 987 | $114K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,183 | $82K |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | <1% | 964 | $70K |
| 81025 | <1% | 4,656 | $36K | |
| H0049 | Alcohol and/or drug screening | <1% | 2,153 | $34K |
| H2015 | Community support for mental illness or disability, per 15 minutes | <1% | 1,558 | $33K |
| 90837 | Psychotherapy session, about an hour | <1% | 361 | $26K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 304 | $18K |
| 99205 | Prolong outpt/office vis | <1% | 228 | $17K |
| 80061 | Lipid panel | <1% | 1,244 | $15K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 153 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 136 | $6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 57 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 160 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 712 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 99 | $5K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 61 | $4K |
| 80306 | <1% | 528 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 815 | $4K |
| H0032 | Mental health service plan development by non-physician | <1% | 40 | $3K |
| 99385 | <1% | 44 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 30 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 26 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 162 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $988.82 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 66 | $679.24 |
| 90674 | <1% | 36 | $559.54 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 37 | $450.16 |
| 99441 | <1% | 21 | $394.23 | |
| 90686 | <1% | 24 | $368.79 | |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | <1% | 18 | $289.41 |
| 91200 | <1% | 21 | $251.06 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 21 | $228.11 |
| 86318 | <1% | 18 | $200.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSE HAAS, SHERI (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Appalachian Wellness Primary Care LLC | Campton, KY | $37K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.